UrSure: the solution to HIV medication adherence

Posted by

Sci Ani

UrSure, Inc., is an HIV prevention startup based at Harvard University that makes diagnostic tests to measure and improve adherence for patients on PrEP for HIV prevention or medication for HIV treatment. We are collaborating with public health departments, researchers, and specialty HIV/AIDS clinics to use our novel, lab-based urine test to help reduce HIV incidence across the US. We are also developing a point-of-care version of our test that will come to market by early 2020.